| Results From Argos Therapeutics' Arcelis™ Immunotherapy Phase 2 Study for ... - PR Newswire (press release) |
|
|
PR Newswire (press release)The study is an open-label Phase 2 trial that enrolled 25 patients with newly diagnosed metastatic clear cell RCC. Post-nephrectomy, subjects received ... read more |